Overview

Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the effects of Xolair using non-invasive techniques from the expired gas of patients with moderate to severe allergic asthma.
Phase:
Phase 4
Details
Lead Sponsor:
Creighton University
Collaborator:
Novartis Pharmaceuticals
Treatments:
Omalizumab